NDC 70860-100-41 - Azithromycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70860-100
- Requested NDC
- 70860-100-41
- Package NDCs from labels
- 70860-100-41, 70860-100-10
- Manufacturer
- Athenex Pharmaceutical Division, LLC.
- Effective date
- 2025-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Azithromycin - Athenex Pharmaceutical Division, LLC. | Athenex Pharmaceutical Division, LLC. | 2025-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70860-100-10 | Azithromycin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 13 | |
| 70860-100-41 | Azithromycin | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 5 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70860-100 | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20250130_324330c5-20fe-4b22-adf2-14a6e91e71ef.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70860-100-10 | EA - Each | 70860-100 | dd577842-230a-4df3-b415-4f4e6fb3a759 | 1 | 2017-03-06 |
| 70860-100-41 | EA - Each | 70860-100 | de9ede2f-242e-4e2e-84f9-478c00ff560b | 1 | 2019-04-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | RB Health Mexico, S.A. de C.V. | 151b9bc9-1a6e-4401-ae58-4b4210ab4505 | 2024-11-15 | Warnings | 2968PHW8QP |
| Lungex II | GINKGO BILOBA, COLON (SUIS), LUNG (SUIS), PANCREAS SUIS, GERMANIUM SESQUIOXIDE, CUPRUM METALLICUM, MANGANUM METALLICUM, STANNUM METALLICUM, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALIC ACID, PYRUVIC ACID, SUCCINICUM ACIDUM, NAPHTHOQUINONE, ARSENICUM METALLICUM, CALCAREA CARBONICA, ACONITICUM ACIDUM, CIS, NATRUM OXALACETICUM, PHOSPHORUS | Energique, Inc. | ddf7fc46-95b7-44b4-b7ca-96a066a3fa2b | 2024-10-28 | Warnings | 2968PHW8QP |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Fresenius Kabi USA, LLC | b69917c0-95d5-4b29-b0e3-07054a4fd79f | 2024-10-11 | Warnings, Adverse reactions | 1668238 JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Fresenius Kabi USA, LLC | 9ad099d5-5c57-4855-98a4-e03fb4629dbf | 2024-10-11 | Warnings, Adverse reactions | 1668238 JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Sagent Pharmaceuticals | 6497fb5e-82d8-4411-b994-7ee01333ffd7 | 2024-09-19 | Warnings, Adverse reactions | ANDA065501 1668238 JTE4MNN1MD |
| AZASITE | AZITHROMYCIN MONOHYDRATE | Thea Pharma Inc. | 0c5d6f5e-18ea-436f-8c62-bbaf66effe3d | 2024-07-25 | Warnings, Adverse reactions | JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 549cdd0a-da79-23b8-e054-00144ff8d46c | 2024-07-17 | Warnings, Adverse reactions | JTE4MNN1MD |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 90a506cd-aae7-a622-e053-2a95a90ad352 | 2024-06-19 | Warnings, Adverse reactions | JTE4MNN1MD |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 82454fb2-e524-ecb8-e053-2991aa0a6e7c | 2024-06-14 | Warnings, Adverse reactions | JTE4MNN1MD |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 8389c336-25eb-a96f-e053-2a91aa0a0dd8 | 2024-06-14 | Warnings, Adverse reactions | JTE4MNN1MD |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 2968PHW8QP |
| Azithromycin | AZITHROMYCIN | Chartwell RX, LLC | 2c9de2e9-c20c-4660-a272-a22019f9fb02 | 2024-04-09 | Warnings, Adverse reactions | JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN | Proficient Rx LP | 44134421-cb0b-4e85-a3c8-d58bdb476fad | 2024-04-01 | Boxed warning, Warnings, Adverse reactions | JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN | STATE HEALTH SERVICES, TEXAS DEPARTMENT OF | 2b821631-0df2-0fb2-e054-00144ff8d46c | 2024-02-29 | Warnings, Adverse reactions | JTE4MNN1MD |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Azithromycin | AZITHROMYCIN | Asclemed USA, Inc. | 9c44af6d-8a9a-cb4c-e053-2a95a90afdac | 2023-09-01 | Warnings, Adverse reactions | JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN | Teva Pharmaceuticals USA, Inc. | f6a52c0b-45db-422e-8c22-e867a11b4439 | 2023-03-01 | Warnings, Adverse reactions | JTE4MNN1MD |
| Azithromycin | AZITHROMYCIN DIHYDRATE | Slate Run Pharmaceuticals | 8acce3c1-f4be-4968-a71f-3ffd9fbaa4a4 | 2022-12-01 | Warnings, Adverse reactions | 1668238 |
| AZITHROMYCIN | AZITHROMYCIN | Proficient Rx LP | e1172805-0930-4fb9-8a2f-e0d6a0430630 | 2022-11-01 | Warnings, Adverse reactions | JTE4MNN1MD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.